Skip to main content

Walking Fish Therapeutics

San Francisco, United States

Walking Fish Therapeutics is developing a platform to harness B cells’ capability to activate the immune system.

$23.0M raised
Feb 2022
Series A

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Walking Fish Therapeutics

How much funding has Walking Fish Therapeutics raised?
Walking Fish Therapeutics has raised $23.0M in total funding. The most recent round was Series A. The last funding was announced in February 2022.
Who are Walking Fish Therapeutics's investors?
Walking Fish Therapeutics's investors include First Spark Ventures, Quan Capital, Illumina Ventures, Emerson Collective, Northpond Ventures.
Where is Walking Fish Therapeutics headquartered?
Walking Fish Therapeutics is headquartered in San Francisco, United States.
What does Walking Fish Therapeutics do?
Walking Fish Therapeutics is developing a platform to harness B cells’ capability to activate the immune system.
What stage is Walking Fish Therapeutics at?
Walking Fish Therapeutics is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Walking Fish Therapeutics — Funding & Investors." VCBacked, February 16, 2022, https://www.vcbacked.co/company/walking-fish-therapeutics. Accessed July 3, 2026.
APA
VCBacked. (2022). Walking Fish Therapeutics — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/walking-fish-therapeutics
Wikipedia (cite web)
{{cite web |title=Walking Fish Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/walking-fish-therapeutics |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .